Original Source
Celltrion to Boost New Drug Development and Manufacturing Efficiency with AI, Humanoids
AI for New Drug Development and Manufacturing Process Innovation
Celltrion is actively adopting AI technology from the initial stages of new drug development to shorten development times and increase success rates. Specifically, the company aims to maximize the efficiency of candidate material discovery and preclinical trials through AI-based data analysis. Furthermore, AI will be applied to manufacturing processes to improve production efficiency and advance quality control systems.
Enhancing Productivity Through Humanoid Robot Adoption
Celltrion is considering the introduction of humanoid robots in its pharmaceutical production facilities. This initiative aims to reduce human error by replacing repetitive tasks with robots and to increase the operational rate of production lines, thereby improving overall productivity. Humanoid robots, with their strengths in precise and repetitive tasks, are expected to contribute to maintaining the quality of pharmaceutical manufacturing.
*Source: Chosunbiz (2026-05-25)*
Related Articles
📧 Daily Newsletter
Get the daily global news briefing in your inbox every morning.
It's still free.